Literature DB >> 9652581

Applications of molecular microbiology to vaccinology.

E R Moxon1.   

Abstract

Genetics, cell biology, and whole-genome sequencing of pathogens have changed dramatically the opportunities to investigate the epidemiology, pathogenesis, diagnosis, and control of microbial diseases. For example, recombinant DNA and PCR are powerful tools used to isolate genes whose role in pathogenicity can be investigated in biologically relevant virulence assays. Vaccines that target one or more of these genes can then be developed. Complete genome sequences of microbes provide an inventory of the genes encoding every virulence factor and potential immunogen. Candidate vaccines can be selected and developed using various approaches, including the recent innovation of immunisation with nucleic acids. Although many successful vaccines have been and will continue to be developed through empirical approaches, molecular microbiology provides a rational basis for discovery, development, and implementation of safer, more effective and, potentially cheaper vaccines.

Mesh:

Substances:

Year:  1997        PMID: 9652581     DOI: 10.1016/S0140-6736(97)03259-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens.

Authors:  R Moxon; C Tang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

2.  From genes to genome biology: a new era in Helicobacter pylori research.

Authors:  N Dorrell; B W Wren
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

3.  Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine.

Authors:  Mohammad Said Ashenagar; Akiko Matsumoto; Hironori Sakai; Mikiko Tokiya; Megumi Hara; Yoshio Hirota
Journal:  Vaccines (Basel)       Date:  2022-03-22

Review 4.  The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.

Authors:  Vega Masignani; Mariagrazia Pizza; E Richard Moxon
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 5.  Mucosal immunity and tolerance: relevance to vaccine development.

Authors:  C Czerkinsky; F Anjuere; J R McGhee; A George-Chandy; J Holmgren; M P Kieny; K Fujiyashi; J F Mestecky; V Pierrefite-Carle; C Rask; J B Sun
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

6.  High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2.

Authors:  Rita Jaafar; Celine Boschi; Sarah Aherfi; Audrey Bancod; Marion Le Bideau; Sophie Edouard; Philippe Colson; Henri Chahinian; Didier Raoult; Nouara Yahi; Jacques Fantini; Bernard La Scola
Journal:  Viruses       Date:  2021-10-28       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.